Perkins Coie advised Xentria Inc. on the deal. Xentria Inc., a clinical-stage biotherapeutics company dedicated to developing novel therapeutics to address unmet medical needs, announced its exclusive...
This content is for Standard 1 Year members only. LoginJoin Now